Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Jeld-Wen Holding Inc (NY: JELD )

12.95 -0.19 (-1.45%)
Streaming Delayed Price Updated: 10:02 AM EDT, Jul 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Jeld-Wen Holding Inc

< Previous 1 2 3 4 5 Next >
Patterson Companies, KB Home And Other Stocks To Watch This Tuesday
Via Benzinga
Here's Why Shares in this Housing Related Stock Slumped in May
Underexposure to the new housing construction market is hurting this door and window company. 
Via The Motley Fool
JELD-WEN Holding Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Via Benzinga
Nasdaq Moves Lower; Great Lakes Dredge & Dock Shares Surge Following Upbeat Earnings
Via Benzinga
12 Industrials Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Jeld-Wen Stock Is Crumbling Today
Sluggish housing construction and remodeling markets are pinching revenues. 
Via The Motley Fool
Recap: JELD-WEN Holding Q4 Earnings
Via Benzinga
Earnings Outlook For JELD-WEN Holding
Via Benzinga
The Latest Analyst Ratings For JELD-WEN Holding
Via Benzinga
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Crude Oil Edges Lower; UBS Shares Jump After Q1 Earnings
Via Benzinga
Exposures Fossil Fuels
Navigating 6 Analyst Ratings For JELD-WEN Holding
Via Benzinga
Expert Ratings for JELD-WEN Holding
Via Benzinga
Expert Ratings for JELD-WEN Holding
Via Benzinga
Earnings Scheduled For November 6, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
Via Benzinga
JELD Stock Earnings: JELD-WEN Holding Beats EPS, Misses Revenue for Q1 2024
JELD stock results show that JELD-WEN Holding beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
BlackRock, Wendy's And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher by more than 250 points on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Finding Investable Companies In The Industrial Sector Is Hard To Do
A lot of the companies are cyclical and a lot of them are unknown, but there are some hidden gems in the sector. 
Via Talk Markets
8 Best Stocks For 2024
In short, 2024 promises to be another uncertain year in the markets. That’s why we’ve had our team of analysts and researchers identify the most promising stocks to keep an eye on in 2024. 
Via Talk Markets
12 Industrials Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Where JELD-WEN Holding Stands With Analysts
Via Benzinga
Where JELD-WEN Holding Stands With Analysts
Via Benzinga
JELD-WEN Holding's Earnings Outlook
Via Benzinga
Top 4 Industrial Stocks That May Explode in October
The most oversold stocks in the industrials sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
JELD-WEN Likely To Post Lower Q2 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
JELD-WEN Holding, Inc. (NYSE: JELD) is expected to report its second quarter financial results, after the closing bell on Aug. 7, 2023. 
Via Benzinga
The Latest Analyst Ratings for JELD-WEN Holding
Via Benzinga
JELD-WEN Divests Australasia Business To Platinum Equity
JELD-WEN Holding, Inc. (NYSE: JELD) completed the previously announced  
Via Benzinga
Why Jeld-Wen Stock Is Up Big This Week
A surprisingly strong quarter suggests the company is holding up well in a tough environment. 
Via The Motley Fool
McKesson, ICU Medical, Novavax And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones dropping around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.